MedTrace Logo

An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Between June 2004 and January 2010

NCT01294553 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 717

Last updated 2017-07-07

Study results available
· View outcomes & findings →

Summary

An open label, multi-centre, non-interventional post-marketing surveillance to monitor the safety and/or efficacy of rosiglitazone/metformin administered in Korean Diabetic patients according to the prescribing information

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DRUG

Administration of rosiglitazone/metformin

Subjects who are administered rosiglitazone/metformin at least once

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2010-01-31
Completion
2010-01-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01294553 on ClinicalTrials.gov